Newsroom

May 8, 2025

RiskScore Study Published in JCO Precision Oncology

Read more
April 25, 2025

Can Humans and Robots Speak the Same Language? Engineering the Labs of Tomorrow

Read more
April 14, 2025

'Happy, healthy and focused' | DNA testing in Mason helps patients find mental health medications faster

Read more
April 1, 2025

Patients Like Olivia Munn and Florence Pugh Are Devoted to Her. Meet Famed OB-GYN, Dr. Thaïs Aliabadi

Read more
March 17, 2025

The outsized impact of employee benefits on HR’s value to an org

Read more
February 12, 2025

Myriad Genetics Included in Forbes America’s Best Employers 2025 List

Read more
February 9, 2025

Hannah Storm's breast cancer diagnosis was a shock. Now the veteran sports journalist is helping others understand their risk

Read more
February 6, 2025

Hannah Storm breaks down latest with NBA trade deadline, Luka Doncic and more

Read more
February 3, 2025

Dallas Reed, MD, highlights trends and barriers in prenatal genetic testing

Read more
previous slide
    next slide

    Scientific publications

    See all

    High positive predictive value 22q11.2 microdeletion screening by prenatal cell-free DNA testing that incorporates fetal fraction amplification

    Read publication
    NPWH 2023

    Menopausal symptom management considerations in patients at high risk for breast cancer

    Read publication
    AUA Western 2023

    Active surveillance selection and durability in men with NCCN intermediate-risk, localized prostate cancer...

    SMFM 2024

    High positive predictive value of 22q11.2 microdeletion screening by prenatal cell-free DNA testing that...

    Read more
    ASCO 2024

    Improving a Polygenic Risk Score (PRS) for breast cancer (BC) risk assessment in diverse ancestries

    Read more
    previous slide
      next slide

      Press releases

      See all

      Sep 04, 2025

      Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology

      Read more

      Sep 03, 2025

      New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression

      Read more

      Aug 27, 2025

      Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

      Read more

      Aug 18, 2025

      Myriad Genetics Appoints Ben Wheeler Chief Financial Officer

      Read more

      Public relations contacts

      Kate Schraml, Megan Manzari

      pr@myriad.com

      Investor relations contacts

      Matt Scalo

      ir@myriad.com
      X social media icon Linkedin social media icon

      About Myriad Genetics

      Myriad Genetics is a leader in genetic testing and precision medicine, providing insights that help people take control of their health and enable healthcare providers to better detect, treat and prevent disease. 

      • Early insights helped Ashley prepare

        “Carrier screening empowers you to make the right decisions. Not only are you making a decision for yourself right now but you’re making a decision for the next 80, 90, 100 years to create a better life for you and your baby.”
        Watch Ashley's story

      • Prenatal screening gave Hannah time to plan

        “Once we got the noninvasive prenatal screening results back, we were able to meet with a lot more physicians.”

      • How Prolaris provided clarity for his prostate cancer treatment plan

        “Prolaris gave me the ability to maintain the lifestyle that my wife and I have lived with for many years now.”
        Watch Tim's story
      previous slide
        next slide